26 results
F-1
EX-10.12
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
and substantial duties hereunder by reason of mental or physical illness, injury or disease which is expected to result in death or be of indefinite duration … for herein.
Death and disability benefits
In the event of the death of the Executive, the Company shall pay to the Executive’s designated
F-1
EX-10.11
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
with the Company for Good Reason. Executive’s Separation from Service by reason of Executive’s death, or discharge by the Company following Executive’s … be terminated immediately on the death of Executive.
(b) Severance Upon Involuntary Termination. Subject to Sections 4(d) and 9(o) and Executive’s continued
F-1/A
EX-10.4
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
or, in the case of his or her death, to the person or persons entitled thereto under Section 12.4, as soon as reasonably practicable … and/or cash, if any, from the Participant’s account under the Plan in the event of such Participant’s death subsequent to a Purchase Date on which
20-F
2021 FY
EX-1.1
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
holder for the time being of the Share, or the Persons entitled thereto by reason of his death or bankruptcy.
22.For giving effect to any such sale … recognised by the Company as having any title to the Share.
43.Any Person becoming entitled to a Share in consequence of the death or bankruptcy
F-1/A
EX-3.2
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
as is presently payable, has been given to the registered holder for the time being of the Share, or the Persons entitled thereto by reason of his death … by the Company as having any title to the Share.
Any Person becoming entitled to a Share in consequence of the death or bankruptcy of a Shareholder shall
F-1
EX-10.1
0fj8rvnuumssv
26 Feb 21
Registration statement (foreign)
4:56pm
DRS
EX-10.1
rqe osb3lfkdfh7
17 Dec 20
Draft registration statement
12:00am
F-1
EX-3.1
7m9x0e188kbjz7
26 Feb 21
Registration statement (foreign)
4:56pm
DRS
EX-3.1
ahybx724mnk9iphq8gd
17 Dec 20
Draft registration statement
12:00am
F-1/A
EX-10.3
19c0 xnjl5ku5
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1/A
EX-10.3
tistlon
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
6-K
EX-99.1
6j9kehdieaq3k qil
5 Jun 23
Current report (foreign)
4:28pm
20-F
EX-4.11
ghbz 3alaknprc2yq
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.10
gztx20dmbo27l0
31 Mar 22
Annual report (foreign)
4:33pm
20-F
EX-4.13
cikodtesmbbkjmem
31 Mar 22
Annual report (foreign)
4:33pm
F-1
EX-4.4
bq1pd wlew
26 Feb 21
Registration statement (foreign)
4:56pm
DRS
EX-4.4
4mm0knx8rz5c45e2kp2
17 Dec 20
Draft registration statement
12:00am
20-F
vjhn1
31 Mar 22
Annual report (foreign)
4:33pm
DRS
abg4cc3x8hjzn
17 Dec 20
Draft registration statement
12:00am
424B4
nlsu9chjqr05fp8
19 Mar 21
Prospectus supplement with pricing info
4:49pm